Circulating levels of soluble Dipeptidylpeptidase-4 are reduced in human subjects hospitalized for severe COVID-19 infections

Dipeptidylpeptidase (DPP)-4 is a key regulator of the incretin system. For several years DPP-4 inhibitors in addition to GLP-1 analogues are of major importance in the clinical management of obesity and type 2 diabetes. DPP-4 is also known as CD26 and represents a membrane bound protease on the surf...

Descripción completa

Detalles Bibliográficos
Autores principales: Schlicht, Kristina, Rohmann, Nathalie, Geisler, Corinna, Hollstein, Tim, Knappe, Carina, Hartmann, Katharina, Schwarz, Jeanette, Tran, Florian, Schunk, Domagoj, Junker, Ralf, Bahmer, Thomas, Rosenstiel, Philip, Schulte, Dominik, Türk, Kathrin, Franke, Andre, Schreiber, Stefan, Laudes, Matthias
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Comment
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7503441/
https://www.ncbi.nlm.nih.gov/pubmed/32958905
http://dx.doi.org/10.1038/s41366-020-00689-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7503441/
https://www.ncbi.nlm.nih.gov/pubmed/32958905
http://dx.doi.org/10.1038/s41366-020-00689-y

Ejemplares similares